JPS52142018A - Essential ion complex - Google Patents

Essential ion complex

Info

Publication number
JPS52142018A
JPS52142018A JP3687877A JP3687877A JPS52142018A JP S52142018 A JPS52142018 A JP S52142018A JP 3687877 A JP3687877 A JP 3687877A JP 3687877 A JP3687877 A JP 3687877A JP S52142018 A JPS52142018 A JP S52142018A
Authority
JP
Japan
Prior art keywords
ion complex
essential ion
essential
complex
ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3687877A
Other languages
English (en)
Other versions
JPS5942683B2 (ja
Inventor
Rakatosu Bera
Meiseru Ne Agosuton Jiyuria
Barujiyu Miharii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magyar Tudomanyos Akademia
Original Assignee
Magyar Tudomanyos Akademia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magyar Tudomanyos Akademia filed Critical Magyar Tudomanyos Akademia
Publication of JPS52142018A publication Critical patent/JPS52142018A/ja
Publication of JPS5942683B2 publication Critical patent/JPS5942683B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/033—Uronic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Saccharide Compounds (AREA)
JP52036878A 1976-03-31 1977-03-31 必須金属イオン複合体 Expired JPS5942683B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU76MA00002754A HU172831B (hu) 1976-03-31 1976-03-31 Sposob poluchenija kompleksov oligo- i poligalakturonnyk kislot s ionami zhiznenno vazhnykh metallov
HU2754/1976 1976-03-31

Publications (2)

Publication Number Publication Date
JPS52142018A true JPS52142018A (en) 1977-11-26
JPS5942683B2 JPS5942683B2 (ja) 1984-10-17

Family

ID=10998832

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52036878A Expired JPS5942683B2 (ja) 1976-03-31 1977-03-31 必須金属イオン複合体

Country Status (14)

Country Link
US (1) US4225592A (ja)
JP (1) JPS5942683B2 (ja)
AU (1) AU513640B2 (ja)
CH (1) CH635111A5 (ja)
DE (1) DE2714128A1 (ja)
DK (1) DK139877A (ja)
FI (1) FI62102C (ja)
FR (1) FR2346367A1 (ja)
GB (1) GB1553749A (ja)
HU (1) HU172831B (ja)
NL (1) NL7703475A (ja)
NO (1) NO771122L (ja)
SE (1) SE7703709L (ja)
SU (2) SU886750A3 (ja)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5798527A (en) * 1980-07-07 1982-06-18 Rgb Lab Mineral enhanced substance and manufacture
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
JPS5998017A (ja) * 1982-07-28 1984-06-06 アルギナ　アクチエンゲゼルシヤフト 多糖類のカルボン酸及び／又は硫酸化多糖類のカルボン酸のカルシウム塩或いはカルシウム混合塩を含有する薬剤
JP2012162485A (ja) * 2011-02-07 2012-08-30 Higashimaru Shoyu Co Ltd 鉄吸収促進剤
JP2014534964A (ja) * 2011-10-13 2014-12-25 ヴィダシム・インコーポレーテッド 鉄−繊維組成物、その調製および使用
JP2017160447A (ja) * 2012-03-30 2017-09-14 エルデーイノバショーン アンパルトセルスカブＲＤＩｎｎｏｖａｔｉｏｎ ＡｐＳ ベンゼンポリカルボン酸化合物及びその薬剤としての使用

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54122731A (en) * 1978-03-13 1979-09-22 Takanao Nagae Composition for treating hepatic disease
JPS5549996A (en) * 1978-10-06 1980-04-11 Fanuc Ltd Motor drive system using pulse width modulation inverter
EP0024797A1 (en) * 1979-07-13 1981-03-11 Imperial Chemical Industries Plc Chiral sugar complexes and process for their preparation
US4447336A (en) * 1981-12-18 1984-05-08 Monsanto Company Stabilized galactomannan gum compositions
US4447337A (en) * 1982-02-24 1984-05-08 Monsanto Company Stabiized galactomannan gum compositions
DE3332301A1 (de) * 1983-09-07 1985-03-21 Algina AG, Zug Metallsalze und metallmischsalze von polymeren, anionischen carbonsaeuren und/oder ihren schwefelsaeureestern, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung
ES8602951A1 (es) * 1985-03-15 1985-12-16 Vinas Lab Procedimiento para la preparacion de un nuevo derivado de lafructosa
US4606831A (en) * 1985-06-17 1986-08-19 Monsanto Company Stabilized galactomannan gum compositions
AU624065B2 (en) * 1987-09-08 1992-06-04 Kabushiki Kaisha Yakult Honsha Liquid food
DE68916640T2 (de) * 1988-11-23 1994-11-17 Mta Koezponti Kemiai Kutato In Basische metallcomplexesaurer oligo-und polysaccharide;obst,gemüse und pharmazeutische zusammensetzungen, welche diese komplexe enthalten.
HU203372B (en) * 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US5472950A (en) * 1989-02-24 1995-12-05 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing cobalt hyaluronic acid complex
US5358702A (en) * 1990-04-10 1994-10-25 Unger Evan C Methoxylated gel particle contrast media for improved diagnostic imaging
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5952308A (en) * 1991-07-29 1999-09-14 Pola Chemical Industries Inc. Mineral absorption promoting agent
FI943242L (fi) * 1993-07-15 1995-01-16 Jcr Pharmaceutical Co Ltd Lääke munuais- ja maksatauteihin
US5626881A (en) * 1995-05-16 1997-05-06 Menefee Mining Corporation Humate dietary supplement
US7033615B2 (en) * 1999-07-09 2006-04-25 Cancer2 Inc. Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
US20030228347A1 (en) * 2000-09-12 2003-12-11 Clark George H. Amino acid chelate for the effective supplementation of calcium magnesium and potassium in the human diet
JP2004155766A (ja) * 2002-10-18 2004-06-03 Arita Junichi 血糖降下作用を有する亜鉛含有物
GB2430881B (en) * 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
GB0707096D0 (en) * 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
RU2527894C2 (ru) 2007-11-27 2014-09-10 Альгифарма ИПР АС Использование альгинатных олигомеров в борьбе с биопленками
RU2404766C1 (ru) * 2009-02-27 2010-11-27 ГОУ ВПО Пятигорская Государственная фармацевтическая академия Министерства здравоохранения и социального развития РФ Антиоксидантное лекарственное средство на основе зерновой послеспиртовой барды
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
CA2764197C (en) 2009-06-03 2017-09-12 Algipharma As Alginate oligomers for use in overcoming multidrug resistance in bacteria
CN109497565B (zh) 2013-03-08 2021-10-26 上海礼邦医药科技有限公司 金属离子-功能性纤维组分络合物组合物、其制备及用途
EP3005872B1 (en) * 2013-06-05 2017-03-15 AHP Cropscience, S.L. Product for regulating plant health, method for obtaining said product and use thereof
CN103435715A (zh) * 2013-09-02 2013-12-11 中国科学院烟台海岸带研究所 寡糖及其衍生物钒配合物的制备方法及其应用
RU2564949C1 (ru) * 2014-10-06 2015-10-10 Федеральное государственное бюджетное учреждение науки Институт органической и физической химии им. А.Е. Арбузова Казанского научного центра Российской академии наук Фармакологическая композиция для повышения адаптационных возможностей организма в условиях физических нагрузок
RU2635762C1 (ru) * 2017-02-27 2017-11-15 Федеральное государственное бюджетное учреждение науки Институт органической и физической химии А.Е. Арбузова Казанского научного центра Российской академии наук Гепатопротекторное средство
RU2704033C1 (ru) * 2019-08-13 2019-10-23 Федеральное государственное бюджетное учреждение науки "Федеральный исследовательский центр "Казанский научный центр Российской академии наук" Фармакологическая композиция на основе водорастворимых полиметаллокомплексов полигалактуроновой кислоты, стимулирующая процесс кроветворения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2518135A (en) * 1946-11-01 1950-08-08 Univ Ohio State Res Found Uniformly 2-substituted glucopyranose polymers
US3074927A (en) * 1960-04-12 1963-01-22 Paul D Saltman Metallic complexes of reducing sugars
US3563978A (en) * 1968-05-15 1971-02-16 Irving L Ochs Polyvalent metal complexes of natural polymers

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5798527A (en) * 1980-07-07 1982-06-18 Rgb Lab Mineral enhanced substance and manufacture
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
JPS5998017A (ja) * 1982-07-28 1984-06-06 アルギナ　アクチエンゲゼルシヤフト 多糖類のカルボン酸及び／又は硫酸化多糖類のカルボン酸のカルシウム塩或いはカルシウム混合塩を含有する薬剤
JP2012162485A (ja) * 2011-02-07 2012-08-30 Higashimaru Shoyu Co Ltd 鉄吸収促進剤
JP2014534964A (ja) * 2011-10-13 2014-12-25 ヴィダシム・インコーポレーテッド 鉄−繊維組成物、その調製および使用
JP2017160447A (ja) * 2012-03-30 2017-09-14 エルデーイノバショーン アンパルトセルスカブＲＤＩｎｎｏｖａｔｉｏｎ ＡｐＳ ベンゼンポリカルボン酸化合物及びその薬剤としての使用

Also Published As

Publication number Publication date
NL7703475A (nl) 1977-10-04
FR2346367A1 (fr) 1977-10-28
SU739077A1 (ru) 1980-06-05
FI62102B (fi) 1982-07-30
US4225592A (en) 1980-09-30
NO771122L (no) 1977-10-03
SU886750A3 (ru) 1981-11-30
FI62102C (fi) 1982-11-10
CH635111A5 (de) 1983-03-15
SE7703709L (sv) 1977-10-01
FI770997A7 (ja) 1977-10-01
AU2376477A (en) 1978-10-05
GB1553749A (en) 1979-09-26
AU513640B2 (en) 1980-12-11
JPS5942683B2 (ja) 1984-10-17
HU172831B (hu) 1978-12-28
FR2346367B1 (ja) 1980-04-25
DE2714128A1 (de) 1977-10-20
DK139877A (da) 1977-10-01

Similar Documents

Publication Publication Date Title
AU517514B2 (en) 3-de-0-methylfortimicins
AU2542577A (en) 4-amino-4-arylcyclohexanones
JPS52125998A (en) Ion source
CS164777A2 (en) Zpusob ziskavani krystalickeho xylitolu farmaceuricke jakosti
GB1522457A (en) Benzocycloheptafurans
GB1545156A (en) Ion drives
AU3191677A (en) Cyclopentan-1-amine
AU2726877A (en) Benzofuranyl-benzimidazoles
JPS52110399A (en) Ion generator
AU507260B2 (en) N-2-imidazolidinylidene-benzeneamine
AU2714177A (en) Phenoxy-hydroxypropylamines
AU2451277A (en) Isothiazolopyridines
GR64048B (en) Ion exchange
AU1309176A (en) Fire-barriers
GB1538366A (en) Pyridobenzodiazepines
BG23251A1 (en) Stabilograph
AU508067B2 (en) Electroradiography
AU2493077A (en) 2-amino-substituted-isothioureido bewzenes
CY1158A (en) Arylmalonamido-1-oxadethiacephalosporins
GB1537670A (en) De-tinning
JPS52103705A (en) Diffebential type reciprocallmotion changinggover means
AU3192177A (en) 2-methoxybenzamides
AU2664077A (en) Frequency-synthesizer-tuner
JPS5240361A (en) O hairetsu
GB1524658A (en) Cyanomethylphenethanolamines